These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14521596)

  • 21. Platelet and blood clotting activation in patients with mitral valve prolapse.
    Martini F; Zuppiroli A; Gori A; Chiarantini E; Fedi S; Prisco D; Cellai A; Boddi V; Abbate R; Dolara A; Gensini G
    Thromb Res; 1996 Aug; 83(4):299-306. PubMed ID: 8870174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
    Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.
    Weisshaar S; Litschauer B; Gouya G; Mayer P; Smerda L; Kapiotis S; Kyrle PA; Eichinger S; Wolzt M
    J Thromb Haemost; 2014 Nov; 12(11):1850-60. PubMed ID: 25211369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage.
    Niemi T; Tanskanen P; Taxell C; Juvela S; Randell T; Rosenberg P
    J Neurosurg Anesthesiol; 1999 Jul; 11(3):188-94. PubMed ID: 10414674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.
    Traby L; Kollars M; Kaider A; Eichinger S; Wolzt M; Kyrle PA
    J Thromb Haemost; 2016 Feb; 14(2):273-81. PubMed ID: 26663880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
    Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of compensatory platelet activation in patients with severe haemophilia, but evidence for a platelet collagen-activation defect.
    Grünewald M; Siegemund A; Grünewald A; Konegen A; Koksch M; Griesshammer M
    Platelets; 2002 Dec; 13(8):451-8. PubMed ID: 12487778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosity.
    Small M; Douglas JT; Aherne GW; Orr M; Lowe GD; Forbes CD; Prentice CR
    Thromb Res; 1982 Feb; 25(4):351-60. PubMed ID: 6122288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cefamandole nafate on blood coagulation and platelet function.
    Custer GM; Briggs BR; Smith RE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):869-72. PubMed ID: 533268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human platelet function by sulfatides.
    Devaiah AK; Raife TJ; Barton JA; Olson JD
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):543-50. PubMed ID: 10997794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential athrombia: study of a new case.
    Inceman S; Tangün Y
    Thromb Diath Haemorrh; 1975 Apr; 33(2):278-85. PubMed ID: 1138423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
    Ruttmann TG; James MF; Aronson I
    Br J Anaesth; 1998 May; 80(5):612-6. PubMed ID: 9691864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
    Cofrancesco E; Colombi M; Gianese F; Cortellaro M
    Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative trials of fluid gelatins on hemostasis in heart surgery in adults].
    Charlet P; Zerr C; Robert D; Merville C; Renouf P; Khayat MC
    Cah Anesthesiol; 1991; 39(4):233-8. PubMed ID: 1933520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on platelet aggregation using the Born method in normal and uraemic dogs.
    Mischke R; Schulze U
    Vet J; 2004 Nov; 168(3):270-5. PubMed ID: 15501144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of different volume therapies on platelet function in the critically ill.
    Boldt J; Müller M; Heesen M; Heyn O; Hempelmann G
    Intensive Care Med; 1996 Oct; 22(10):1075-81. PubMed ID: 8923073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.